Role of oral misoprostol 600 mcg in active management of third stage of labour: a comparative study with carboprost 125 mcg, intramuscular

Rekha Ramappa, Hema Mohan, Lepakshi B. Gurusiddappa

Abstract


Background: Objectives: To compare misoprostol 600 mcg, oral with carboprost 125 mcg, i.m., in the active management of third stage of labour.

Methods: A total of 200 pregnant women of 38-42 weeks of gestation delivering vaginally in the Shivamogga institute of medical sciences, Shivamogga, Karnataka, India were selected for study. 100 women received misoprostol 600 mcg, orally and 100 women received carboprost 125 mcg, i.m. immediately after delivery of baby and cord clamping by the method of randomisation.

Results: In the misoprostol group, mean blood loss is 134.9 ml, mean duration of the third stage of labour is 4.07 min and mean fall in hemoglobin is 0.34 g/dl. In the carboprost group, mean blood loss is 123.7 ml, mean duration of the third stage of labour is 3.73 min and mean fall in hemoglobin is 0.28 g/dl. There was no significant difference between the two groups with regard to the above mentioned factors. There were 5 cases of PPH in the misoprostol group and 3 cases in the carboprost group. 21 cases in the misoprostol group and 14 cases in the carboprost group required additional oxytocics. Unpleasant side effects like diarrhoea and vomiting were more in carboprost group.  

Conclusion: Oral misoprostol is as effective as carboprost in AMTSL and can be used safely in vaginal deliveries for prevention of PPH, especially in non-institutional deliveries and in places of low resource settings.

 


Keywords


Misoprostol, Carboprost, Active management of third stage of labour (AMTSL), Postpartum hemorrhage (PPH), Severe acute maternal morbidity (SAMM), Maternal mortality rate (MMR)

Full Text:

PDF

References


Office of Registrar General, India, Ministry of Home Affairs, Government of India. Special bulletin on maternal mortality in India: 2007-2009, June 2011. Available at: http://www.censusindia.gov.in/vital_statistics/SRS_Bulletins/Fin al-MMR%20Bulletin-2007-09_070711.pdf. Accessed 10 February 2013.

International Confederation of Midwives, International Federation of Gynecologists & Obstetricians. Joint statement: management of the third stage of labour to prevent post-partum haemarrhage. J Midwifery Women’s Health. 2004;49:76-7.

Smit M, van Stralen G, Wolterbeek R, van Dillen J, van Roosmalen J, Slootweg Y. Survey of prophylactic use of uterotonics in the third stage of labour in the Netherlands. Midwifery. 2013 Aug;29(8):859-62.

Howell C, Grady K, Cox C. Massive obstetric haemorrhage. In: Howell C, Grady K, Cox C, eds. Managing Obstetric Emergencies and Trauma: the MOET Course Manual. 2nd ed. London, UK: Royal College of Obstetricians and Gynaecologists; 2007: 179.

Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomized trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689-95.

Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet. 2006;368:1248-53.

Alfirevic A, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynecol Obstet. 2007;99(Suppl 2):198-201.